Abstract: The invention relates to antimicrobial preparations which comprise octenidine dihydrochloride in liposomes. The invention additionally relates to a process for manufacturing the preparations and to the use of phospholipids for manufacturing antimicrobial preparations which comprise octenidine dihydrochloride. The preparations show a low cytoxicity.

Abstract: A medicinal composition and method to treat or minimize post-ischemic brain cell deterioration that comprises nitrous oxide or a nitrous oxide donor and xenon or a xenon donor. The medicinal composition may be administered prior to or subsequent to a stroke.

Abstract: The invention relates to a liquid concentrate for the preservation of cosmetic an pharmaceutical prod nets which comprises 3-iodo-2-propynyl butylcarbamate (IPBC), at least on liquid carrier selected from the group consisting of: polyvalent alcohols, glycol esters and glycol ethers, and at least one stabilizer selected from the group consisting of: formic acid, formic acid salts, and format esters, and comprising no additional carboxylic acid selected from the group consisting of: benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid and 10-undecylenic acid and a salt thereof being present.

Abstract: The invention relates to an alkaline disinfecting and cleaning composition which comprises one or more selected quaternary ammonium salts, one or more selected alcohol alkoxylates and one or more alkylamines. By exact choice of the components a composition is provided which can be formulated as concentrate and, as dilute aqueous ready-to-use solution, has good cleaning efficiency combined with good microbicidal activity.

Abstract: The invention relates to a method for monitoring and managing a cryostorage installation comprising at least one container or at least one refrigerator (3, 4), in which the samples to be stored are placed, in a refrigerated atmosphere, the said at least one container or refrigerator (3, 4) being placed in at least one room (A).

Abstract: A liquid, cold-temperature-stabilized preservative is based on carbendazim or a salt thereof, which includes, as low-temperature stabilizer, at least one aromatic alcohol and/or at least one aromatic glycol ether and/or a pyrrolidone.

Abstract: The invention relates to a liquid concentrate for the preservation of cosmetic and pharmaceutical products which comprises 3-iodo-2-propynyl butylcarbamate (IPBC), at least one liquid carrier selected from the group consisting of: polyvalent alcohols, glycol esters and glycol ethers, and at least one stabilizer selected from the group consisting of: formic acid, formic acid salts, and formate esters, and comprising no additional carboxylic acid selected from the group consisting of: benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid and 10-undecylenic acid and a salt thereof being present.

Abstract: The invention relates to microbicidal preparations which comprise a) at least one of 1,2-benzisothiazolin-3-one and its derivatives, b) at least one of 2-mercaptopyridine N-oxide, its salts and derivatives and c) at least one alkalinizing agent, or which are prepared by mixing components a) to c), where the preparations have a pH of at least 11. The preparations are characterized by the fact that they are clear and storage-stable, and they are suitable for use as preservatives.

Abstract: A method of manufacturing a gas mixture of at least two components. Oxygen, nitrogen, helium, carbon dioxide, nitrous oxide, and carbon monoxide are all suitable for use as components in this method. Defined amounts of the components are dynamically mixed in order to obtain a first gas mixture at a first pressure less than 200 bar. The first gas mixture contains an intermediate amount of the second component which is less than the amount desired in the final gas mixture. A first component is then added to the first gas mixture to concomitantly dilute the second component. The addition of the first component is stopped when the pressure of the diluted gas mixture reaches a second pressure greater than both the first pressure and 170 bar, and when the diluted gas mixture contains the desired final proportion of the second component.

Abstract: Cooling lubricant (concentrate or solution) comprising a cooling lubricant base based on mineral and/or synthetic oil and preservative comprising (a) one or more 1- or 2-(C3 to C24 alkyl) glyceryl ethers.

Abstract: Cooling lubricant (concentrate or solution) comprising a cooling lubricant base based on mineral and/or synthetic oil and preservative comprising (a) one or more 1- or 2-(C3 to C24 alkyl)glyceryl ethers.

Abstract: Methods and compositions for a concentrated alkaline disinfectant. The disinfectant includes a quaternary ammonium salt, a guanidine derivative, an alcohol ethoxylate with between 5 and 7 EO units, alkylamine, an acid, and aromatic alcohol.

Abstract: A liquid, cold-temperature-stabilized preservative is based on carbendazim or a salt thereof, which includes, as low-temperature stabilizer, at least one aromatic alcohol and/or at least one aromatic glycol ether and/or a pyrrolidone.

Abstract: A liquid, cold-temperature-stabilized preservative is based on carbendazim or a salt thereof, which includes, as low-temperature stabilizer, at least one aromatic alcohol and/or at least one aromatic glycol ether and/or a pyrrolidone.

Abstract: The present invention relates to compositions which comprise a combination a) of one or more glycerol monoalkyl ether(s) of the general formula R—O—CH2—CHOH—CH2OH in which R is a branched or unbranched C3-C18-alkyl group, where the alkyl group can be substituted by one or more hydroxyl and/or C1-C4-alkoxy group(s) and/or the alkyl chain can be interrupted by up to four oxygen atoms, with b) an antioxidant or two or more antioxidants as stabilizer(s), the simultaneous presence of phosphocholines and phosphocholine derivatives being excluded.

Abstract: The invention concerns the use of at least one gas in combination with at least one active product for manufacturing an inhalable medicament or part of an inhalable medicament intended for the treatment or prevention of pain in humans or animals. The gas is chosen from among helim, oxygen, nitrogen, xenon, hydrogen, carbon monoxide (CO), carbon dioxide (CO2), argon, krypton, nitrogen monoxide (NO), nitrogen protoxide (N2O), carbonated hydrocarbons, fluorocarbons and mixtures of several of these gases. The active product is chosen from among paracetamol, acetylsalicylic acid, arylcarboxylic acid, corticosteroids, mineralosteroids, non-steoroidal anti-inflammatory drugs and their derivatives, codeine and its derivatives, morphine and morphine mimetics.

Abstract: A disinfectant composition and process for making the same. The composition comprises octenidine dihydrochloride, at least one C1 to C8-alkyl alcohol, at least one surfactant chosen among non-ionic or cationic surfactants, water and optionally at least one ?-hydroxycarboxylic acid.

Abstract: Stable microbicidal compositions for industrial products which comprise a) at least one bactericidal N-formal, b) at least one fungicide and c) at least one stabilizer.

Abstract: The invention relates to a ready-to-use binary gaseous mixture containing 63.1 to 69.9% by volume of helium and the remainder being oxygen, preferably a mixture of 65% of helium and of 35% of oxygen, and its use in the treatment of asthma, of obstructive bronchopneumopathies and the like. Such a gaseous mixture can be used as a vector or propellant gas for medicinal aerosols, in particular aerosols containing a therapeutically effective substance chosen from &bgr;2-mimetics, corticoids and anticholinergics.

Abstract: A process for the dynamic manufacture and packaging of gas mixtures containing a first component and a second component in predefined proportions, the first and second components being chosen from the group formed by O2, N2, He and N2O, in which predetermined proportions of the first and second components are dynamically mixed in order to obtain a gas mixture of the desired composition and the temperature of the mixture is adjusted in order to keep it above the demixing threshold temperature of the mixture. This process is particularly suitable for the production of analgesic gas mixtures that can be used in the medical field, particularly a mixture formed from 50% oxygen and 50% nitrous oxide.